Zymeworks Biopharmaceuticals 401(K) Plan — Form 5500 plan (Zymeworks Biopharmaceuticals Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Zymeworks Biopharmaceuticals 401(K) Plan is a benefit plan reported by Zymeworks Biopharmaceuticals Inc. under EIN 47-2569713 and plan number 001. The latest loaded filing year is 2023. The filing reports 225 participants and $11,966,451 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Zymeworks Biopharmaceuticals Inc.
EIN
47-2569713
Plan number
001
Plan type
2
Location
not reported in the loaded dataset
Latest filing year
2023
Participants
225
End-of-year plan assets
$11,966,451

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023225H, C20240503142847NAL0029872577001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$11,966,451
Total liabilities (EOY)
$0
Net assets (EOY)
$11,966,451
Net assets (BOY)
$11,125,643

Income & contributions

Employer contributions
$1,182,268
Participant contributions
$1,644,036
Total contributions
$3,065,310
Total income / additions
$5,339,466

Expenses & distributions

Benefits paid
$4,340,540
Administrative expenses
$158,118
Total expenses
$4,498,658
Net increase / (decrease)
$840,808

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Empower Annuity Ins. Co. Of AmericaRECORDKEEPER$109,016not reported in the loaded dataset2023
Morgan Stanley Smith Barney LLCBROKER/ADVISER$0$48,2112023
Definiti LLCCONTRACT ADMIN$7,812$10,0002023
Leafhouse Financial Advisors, LLCOTHER$5,171not reported in the loaded dataset2023
Morgan Stanley Insurance Services IBROKER/ADVISER$0$5822023

Related Form 5500 pages